Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 9 (September)

1. Placental drainage of fetal blood at cesarean delivery and feto maternal transfusion: a randomized controlled trial.
   Obstet Gynecol, 110(3): 608-11. [Abstract] [Full-text]
2. A case of persistent anemia and alcohol abuse.
   Nat Clin Pract Gastroenterol Hepatol, 4(9): 521-6. [Abstract] [Full-text]
3. Structure of the cytoplasmic domain of erythrocyte band 3 hereditary spherocytosis variant P327R: band 3 Tuscaloosa.
   Biochemistry, 46(36): 10248-57. [Abstract] [Full-text]
4. Hodgkin lymphoma in a child with sickle cell anemia.
   Pediatr Hematol Oncol, 24(7): 531-5. [Abstract] [Full-text]
5. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
   Pediatr Hematol Oncol, 24(7): 481-91. [Abstract] [Full-text]
6. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
   Pediatr Hematol Oncol, 24(7): 469-79. [Abstract] [Full-text]
7. Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
   Am J Health Syst Pharm, 64(18): 1943-9. [Abstract] [Full-text]
8. Case report of HbC/beta(0)-thalassemia from India.
   Int J Lab Hematol, 29(5): 381-5. [Abstract] [Full-text]
9. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation.
   Int J Lab Hematol, 29(5): 341-6. [Abstract] [Full-text]
10. Evaluation of reticulocyte parameters in iron deficiency, vitamin B(12) deficiency and beta-thalassemia minor patients.
    Int J Lab Hematol, 29(5): 327-34. [Abstract] [Full-text]
11. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Int J Lab Hematol, 29(5): 321-6. [Abstract] [Full-text]
12. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
    Br J Haematol, 139(1): 3-13. [Abstract] [Full-text]
13. Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients.
    Br J Haematol, 139(1): 148-58. [Abstract] [Full-text]
14. Murine glutathione S-transferase A1-1 in sickle transgenic mice.
    Am J Hematol, 82(10): 911-5. [Abstract] [Full-text]
15. Parenteral iron therapy is associated with a characteristic pattern of iron staining on bone marrow aspirate smears.
    Am J Clin Pathol, 128(4): 590-3. [Abstract] [Full-text]
16. Usefulness of cell counter-based parameters and formulas in detection of beta-thalassemia trait in areas of high prevalence.
    Am J Clin Pathol, 128(4): 585-9. [Abstract] [Full-text]
17. Maternal anaemia as an indicator for monitoring malaria control in pregnancy in sub-Saharan Africa.
    BJOG, 114(10): 1222-31. [Abstract] [Full-text]
18. The effects of iron deficiency on neutrophil/monocyte apoptosis in children.
    Cell Prolif, 40(5): 741-54. [Abstract] [Full-text]
19. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
    Nat Rev Genet, 8(10): 735-48. [Abstract] [Full-text]
20. G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors.
    Bone Marrow Transplant, 40(7): 677-81. [Abstract] [Full-text]
21. Laboratory markers of thrombosis risk in children with hereditary spherocytosis.
    Pediatr Blood Cancer, 49(6): 781-5. [Abstract] [Full-text]
22. Hyperbaric oxygen should not be used in the management of hemorrhagic cystitis in patients with Fanconi anemia.
    Pediatr Blood Cancer, 49(6): 854-6. [Abstract] [Full-text]
23. West syndrome in an infant with vitamin B12 deficiency in the absence of macrocytic anaemia.
    Dev Med Child Neurol, 49(10): 774-6. [Abstract] [Full-text]
24. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.
    Blood, 110(7): 2708-17. [Abstract] [Full-text]
25. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.
    Blood, 110(7): 2749-56. [Abstract] [Full-text]
26. A network model to predict the risk of death in sickle cell disease.
    Blood, 110(7): 2727-35. [Abstract] [Full-text]
27. Fear of movement (kinesiophobia), pain, and psychopathology in patients with sickle cell disease.
    Clin J Pain, 23(8): 707-13. [Abstract] [Full-text]
28. Routine iron supplementation in pregnancy has no effect on iron status of children at six months and four years of age.
    J Pediatr, 151(4): 438-40. [Abstract] [Full-text]
29. Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis?
    J Pediatr, 151(4): 435-7. [Abstract] [Full-text]
30. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
    Hematology, 12(5): 361-70. [Abstract] [Full-text]
31. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
    CMAJ, 177(7): 725-34. [Abstract] [Full-text]
32. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
    Am Heart J, 154(4): 645.e9-15. [Abstract] [Full-text]
33. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Cancer, 110(7): 1520-6. [Abstract] [Full-text]
34. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
    Cancer, 110(7): 1629-40. [Abstract] [Full-text]
35. Infant feeding in the second 6 months of life related to iron status: an observational study.
    Arch Dis Child, 92(10): 850-4. [Abstract] [Full-text]
36. Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
    Ann Hematol, 86(11): 837-41. [Abstract] [Full-text]
37. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
    Mol Immunol, 45(1): 95-105. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.